Microfluidic hemoperfusion device for treatment of sepsis
Oregon State University, OR, United States
We have developed a platform technology that leverages high flow rate microfluidics and advanced surface coatings to enable safe and efficient removal of pathogenic entities from blood. As an initial application we are focusing on removal of endotoxin for treatment of sepsis.
Primary Application Area: Medical Devices
Technology Development Status: Concept
Technology Readiness Level: TRL 3
FIGURES OF MERIT
Value Proposition: Our technology will enable significantly improved adsorption efficiency and reduced damage to blood cells by leveraging microfabrication capabilities to precisely control the geometry of the blood flow path and by applying a coating to the device surface that imparts biocompatibility and improved capacity to bind endotoxin.
Organization Type: Academic/Gov Lab
Showcase Booth #: 501
GOVT/EXTERNAL FUNDING SOURCES
Government Funding/Support to Date: NSF PFI: AIR-TT program, $200,000, July 2014-Dec. 2015
Primary Sources of Funding: Federal Grant, University
Looking for: Both Funding and Development Partners